Credit Suisse initiated coverage on Stratasys with a new price target
$SSYS
Computer peripheral equipment
Technology
Credit Suisse initiated coverage of Stratasys with a rating of Outperform and set a new price target of $24.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/13/2024 | $24.00 | Overweight | Cantor Fitzgerald |
| 1/4/2023 | $15.00 | Hold → Buy | Needham |
| 11/8/2022 | Underperform → Mkt Perform | William Blair | |
| 8/17/2022 | $24.00 | Outperform | Credit Suisse |
| 5/17/2022 | $25.00 → $23.00 | Underweight → Neutral | JP Morgan |
| 2/24/2022 | $30.00 | Hold → Buy | Cross Research |
| 11/4/2021 | Neutral → Underweight | JP Morgan | |
| 11/4/2021 | Overweight → Neutral | JP Morgan |
SD - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00
Needham upgraded Stratasys from Hold to Buy and set a new price target of $15.00
William Blair upgraded Stratasys from Underperform to Mkt Perform
New Center of Excellence to serve as a catalyst for global expansion of advanced additive tooling solutions for automotive and industrial manufacturers Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of the North American Stratasys Tooling Center (NASTC), a new collaboration with Automation Intelligence, LLC (AI), at AI's manufacturing site in Flint, Michigan. This dedicated tooling hub is designed to assist manufacturers validate and scale practical applications for additive manufacturing in production environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250611034678/en/Robotic arm that is being used in the ne
Revenue of $136.0 million, compared to $144.1 million in the prior year period GAAP net loss of $13.1 million, or $0.18 per diluted share, and non-GAAP net income of $2.9 million, or $0.04 per diluted share Adjusted EBITDA of $8.2 million, compared to $4.1 million in the prior year period $150.1 million cash, equivalents and short-term deposits and no debt at March 31, 2025 Adds $120 million in cash from investment by Fortissimo Capital subsequent to quarter end Raises 2025 Outlook Stratasys Ltd. (NASDAQ:SSYS), a leader in polymer 3D printing solutions, today announced its financial results for the first quarter ended March 31, 2025. Dr. Yoav Zeif, Stratasys' Chief Executive O
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025. The Company plans to hold the conference call to discuss its first quarter 2025 financial results on Thursday, May 8, 2025, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=pGlPRdRX To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior
Revenue of $136.0 million, compared to $144.1 million in the prior year period GAAP net loss of $13.1 million, or $0.18 per diluted share, and non-GAAP net income of $2.9 million, or $0.04 per diluted share Adjusted EBITDA of $8.2 million, compared to $4.1 million in the prior year period $150.1 million cash, equivalents and short-term deposits and no debt at March 31, 2025 Adds $120 million in cash from investment by Fortissimo Capital subsequent to quarter end Raises 2025 Outlook Stratasys Ltd. (NASDAQ:SSYS), a leader in polymer 3D printing solutions, today announced its financial results for the first quarter ended March 31, 2025. Dr. Yoav Zeif, Stratasys' Chief Executive O
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025. The Company plans to hold the conference call to discuss its first quarter 2025 financial results on Thursday, May 8, 2025, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=pGlPRdRX To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior
CollPlant announces six-month study data from its regenerative breast implant program, which could provide a revolutionary alternative to women for aesthetic or medical purposes and aims to address a $3 billion market opportunity Recently received a $2 million development payment from AbbVie Conference call to be held today at 10:00 a.m. U.S. EDT REHOVOT, Israel, March 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced its 2024 financial results and provided a corp